주입 백 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 재료별, 용량별, 최종 용도별 및 부문별 예측(2026-2033년)

Infusion Bags Market Summary

The global infusion bags market size was estimated at USD 8.21 billion in 2025 and is projected to grow from USD 8.82 billion in 2026 to USD 14.55 billion by 2033, at a CAGR of 7.42% from 2026 to 2033. North America dominated the infusion bags market with 39.08% of revenue share in 2025.

The infusion bags market is growing steadily, driven by the increasing demand for safe and efficient intravenous drug delivery systems across hospitals, ambulatory surgical centers, and home healthcare settings. Infusion bags are widely used for the administration of fluids, medications, parenteral nutrition, blood products, and biologics in the treatment of chronic diseases, critical care conditions, and surgical procedures. The rising prevalence of cancer, diabetes, cardiovascular disorders, and renal diseases is significantly increasing the volume of infusion therapies globally. In addition, the growing number of surgical procedures, expanding aging population, and increasing hospitalization rates are strengthening the demand for sterile and high-performance infusion solutions. Technological advancements in non-PVC and multilayer infusion bag materials with improved drug compatibility, reduced leachable, and enhanced patient safety are further supporting market growth. Furthermore, the increasing adoption of ready-to-use infusion systems and the expansion of home infusion therapy are accelerating the utilization of advanced infusion bags across healthcare facilities and homecare environments.

The increasing volume of hospital admissions, surgical procedures, and critical care treatments is one of the primary factors driving the growth of the infusion bags market. Infusion bags are extensively used for the administration of saline, electrolytes, antibiotics, hydration fluids, and other intravenous therapies across hospitals, emergency departments, intensive care units, and outpatient settings. The growing burden of chronic diseases such as cardiovascular disorders, diabetes, cancer, and renal diseases has significantly increased the demand for long-term infusion therapy, thereby supporting higher consumption of sterile infusion bags globally.

Infusion Bags Market Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the infusion bags market report based on product type, material, capacity, end use, and region:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Basic Sterile IV Empty Containers
• Parenteral Nutrition (TPN) Empty Bags
• Chemotherapy Empty Infusion Bags
• Blood Collection & Transfusion Empty Bags
• Material (Revenue, USD Million, 2021 - 2033)
• PVC-Based Empty Infusion Bags
• Non-PVC Empty Infusion Bags
• Capacity (Revenue, USD Million, 2021 - 2033)
• <250 mL
• 250-1000 mL
• 1000-2000 mL
• >2000 mL
• End Use (Revenue, USD Million, 2021 - 2033)
• Hospital
• Outpatient Facilities
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Material
  • 1.1.3. Capacity
  • 1.1.4. End Use
  • 1.1.5. Regional scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Infusion Bags Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Consumer Behavior Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising demand for IV therapies
    • 3.3.1.2. Increasing prevalence of chronic diseases
    • 3.3.1.3. Expansion of ICU, surgical, and critical care infrastructure globally
    • 3.3.1.4. Strong shift toward non-PVC infusion bags due to DEHP safety concerns and regulatory pressure.
    • 3.3.1.5. Growth in blood transfusion and collection procedures supporting demand for higher-capacity bags
    • 3.3.1.6. Rising adoption of single-use sterile systems in hospital procurement policies.
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Higher cost of non-PVC infusion bags compared to PVC alternatives
    • 3.3.2.2. Limited adoption in price-sensitive and developing markets
  • 3.3.3. Market Opportunity Analysis
    • 3.3.3.1. Rapid growth in non-PVC segments across oncology and parenteral nutrition applications
    • 3.3.3.2. Expansion of healthcare infrastructure in emerging markets
    • 3.3.3.3. Increasing adoption of hospital compounding pharmacies and clinical trial applications
    • 3.3.3.4. Growth in outpatient and home healthcare demand
    • 3.3.3.5. Development of eco-friendly and sustainable infusion bag materials
    • 3.3.3.6. Rising blood banking and transfusion service expansion
  • 3.3.4. Market Challenge Analysis
    • 3.3.4.1. Intense price competition from PVC-based products
    • 3.3.4.2. Regulatory variation across regions
• 3.4. Infusion Bags Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Bargaining power of suppliers
    • 3.4.1.2. Bargaining power of buyers
    • 3.4.1.3. Threat of substitutes
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Technological landscape
    • 3.4.2.5. Environmental landscape
    • 3.4.2.6. Legal landscape

Chapter 4. Infusion Bags Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Infusion Bags Market: Product Type Movement Analysis
• 4.3. Infusion Bags Product Type (Outlook (USD Million))
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Basic Sterile IV Empty Containers
  • 4.5.1. Basic Sterile IV Empty Containers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Parenteral Nutrition (TPN) Empty Bags
  • 4.6.1. Parenteral Nutrition (TPN) Empty Bags Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Chemotherapy Empty Infusion Bags
  • 4.7.1. Chemotherapy Empty Infusion Bags Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Blood Collection & Transfusion Empty Bags
  • 4.8.1. Blood Collection & Transfusion Empty Bags Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Infusion Bags Market: Material Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Infusion Bags Market: Material Movement Analysis
• 5.3. Infusion Bags Material Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. PVC-Based Empty Infusion Bags
  • 5.5.1. PVC-Based Empty Infusion Bags Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Non-PVC Empty Infusion Bags
  • 5.6.1. Non-PVC Empty Infusion Bags Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Infusion Bags Market: Capacity Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Infusion Bags Market: Capacity Movement Analysis
• 6.3. Infusion Bags Capacity Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. <250 mL
  • 6.5.1. <250 mL Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. 250-1000 mL
  • 6.6.1. 250-1000 mL Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. 1000-2000 mL
  • 6.7.1. 1000-2000 mL Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. >2000 mL
  • 6.8.1. >2000 mL Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Infusion Bags Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Infusion Bags Market: End Use Movement Analysis
• 7.3. Infusion Bags End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Hospitals
  • 7.5.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Outpatient Facilities
  • 7.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Infusion Bags Market: Regional Estimates & Trend Analysis, by Product Type, by Application, by Material, by Capacity, and by End Use

• 8.1. Regional Dashboard
• 8.2. Regional Infusion Bags Market Movement Analysis & Market Share, 2025 & 2033
• 8.3. Infusion Bags Market: Regional Estimates & Trend Analysis
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. North America
  • 8.5.1. North America Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Europe
  • 8.5.6. Europe Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. UK
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. UK Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Germany
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Germany Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. France
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. France Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.10. Italy
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Reimbursement scenario
    • 8.5.10.5. Italy Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.11. Spain
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Reimbursement scenario
    • 8.5.11.5. Spain Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.12. Denmark
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Reimbursement scenario
    • 8.5.12.5. Denmark Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.13. Sweden
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Reimbursement scenario
    • 8.5.13.5. Sweden Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.14. Norway
    • 8.5.14.1. Key Country Dynamics
    • 8.5.14.2. Competitive Scenario
    • 8.5.14.3. Regulatory Framework
    • 8.5.14.4. Reimbursement scenario
    • 8.5.14.5. Norway Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Japan Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. China Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. India Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. South Korea Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Australia Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Thailand Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Brazil Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Argentina Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. South Africa Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Saudi Arabia Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. UAE Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Kuwait Infusion Bags Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Share Analysis, 2025
• 9.3. Pricing Analysis
• 9.4. Key Company Profiles
  • 9.4.1. Terumo
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Fresenius Kabi Deutschland GmbH
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Baxter
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. B. Braun SE
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Kapsam Health Products
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. EcoFLX (Douglas Medical Products)
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Boen Healthcare Co., Ltd.
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. VALMED s.r.l.
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. MITRA
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. ICU Medical, Inc.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives
  • 9.4.11. Sippex IV bags
    • 9.4.11.1. Company overview
    • 9.4.11.2. Financial performance
    • 9.4.11.3. Product benchmarking
    • 9.4.11.4. Strategic initiatives
  • 9.4.12. Technoflex (Adagia Partners)
    • 9.4.12.1. Company overview
    • 9.4.12.2. Financial performance
    • 9.4.12.3. Product benchmarking
    • 9.4.12.4. Strategic initiatives
  • 9.4.13. Bioteque Corporation
    • 9.4.13.1. Company overview
    • 9.4.13.2. Financial performance
    • 9.4.13.3. Product benchmarking
    • 9.4.13.4. Strategic initiatives
  • 9.4.14. Helapet
    • 9.4.14.1. Company overview
    • 9.4.14.2. Financial performance
    • 9.4.14.3. Product benchmarking
    • 9.4.14.4. Strategic initiatives
  • 9.4.15. Merit Pharmaceutical
    • 9.4.15.1. Company overview
    • 9.4.15.2. Financial performance
    • 9.4.15.3. Product benchmarking
    • 9.4.15.4. Strategic initiatives
  • 9.4.16. AdvaCare Pharma
    • 9.4.16.1. Company overview
    • 9.4.16.2. Financial performance
    • 9.4.16.3. Product benchmarking
    • 9.4.16.4. Strategic initiatives
  • 9.4.17. Polymed
    • 9.4.17.1. Company overview
    • 9.4.17.2. Financial performance
    • 9.4.17.3. Product benchmarking
    • 9.4.17.4. Strategic initiatives
  • 9.4.18. JMS North America Corporation
    • 9.4.18.1. Company overview
    • 9.4.18.2. Financial performance
    • 9.4.18.3. Product benchmarking
    • 9.4.18.4. Strategic initiatives
  • 9.4.19. Other Players